XL FLEET CORP (XL)

US9837FR1002 - Common Stock

1.14  +0.27 (+30.91%)

After market: 1.07 -0.07 (-6.14%)

Fundamental Rating

2

XL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 42 industry peers in the Automobile Components industry. XL has a bad profitability rating. Also its financial health evaluation is rather negative. XL is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

XL had negative earnings in the past year.
XL had a negative operating cash flow in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -14.54%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -346.62%
PM (TTM) -270.63%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

XL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XL has more shares outstanding
The debt/assets ratio for XL is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 5.34 indicates that XL is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.00 indicates that XL is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.34
ROIC/WACCN/A
WACC10.23%

2.3 Liquidity

A Current Ratio of 29.07 indicates that XL has no problem at all paying its short term obligations.
XL has a Quick Ratio of 27.87. This indicates that XL is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 29.07
Quick Ratio 27.87

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.15% over the past year.
The Revenue for XL has decreased by -23.10% in the past year. This is quite bad
EPS 1Y (TTM)41.15%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q0%
Revenue 1Y (TTM)-23.1%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q-18.52%

3.2 Future

XL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.59% yearly.
The Revenue is expected to grow by 81.97% on average over the next years. This is a very strong growth
EPS Next Y-171.92%
EPS Next 2Y-84.92%
EPS Next 3Y-71.3%
EPS Next 5Y-14.59%
Revenue Next Year80.69%
Revenue Next 2Y77.77%
Revenue Next 3Y98.9%
Revenue Next 5Y81.97%

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.48

4.3 Compensation for Growth

A cheap valuation may be justified as XL's earnings are expected to decrease with -71.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-84.92%
EPS Next 3Y-71.3%

0

5. Dividend

5.1 Amount

No dividends for XL!.
Industry RankSector Rank
Dividend Yield N/A

XL FLEET CORP

NYSE:XL (11/11/2022, 7:04:00 PM)

After market: 1.07 -0.07 (-6.14%)

1.14

+0.27 (+30.91%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap164.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -346.62%
PM (TTM) -270.63%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 29.07
Quick Ratio 27.87
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)41.15%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-171.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-23.1%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y